Summary
Chemotaxis has recently been implicated in tumor metastasis. Protein Kinase C(PKC)ζ is often over-activated and is a key signal transducer shared by both EGFR- and CXCR4-mediated chemotactic signaling in human breast and lung cancers, as well as CSF-1-induced macrophage migration. In order to develop potential inhibitors targeting PKCζ for effective blockage of cancer cell chemotaxis and tumor metastasis, the Z′-LYTE™ KINASE ASSAY -SER/THR 7 PEPTIDE Kit was used and a compound called PKCzI257.3 was identified with IC50 of 28 µM. As a result of treatment, chemotactic migration potency of the human breast cancer cell MDA-MB-231 were impaired, while no significant effect was observed on cell proliferation. Furthermore, EGF-induced cofilin phosphorylation, a critical step of cofilin recycle and actin polymerization, was also dampened, which was relevant to the decreased cell migration. Our results suggest that PKCzI257.3 is a PKCζ-specific compound inhibitor which blocked cancer cell migration and may serve as a potential therapeutic drug for cancer treatment.
Similar content being viewed by others
References
Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89–96. doi:10.1006/scbi.2001.0416
Ben Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356. doi:10.1007/s10585-007-9097-3
Payne AS, Cornelius LA (2002) The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118:915–922. doi:10.1046/j.1523-1747.2002.01725.x
Comer FI, Parent CA (2002) PI 3-kinases and PTEN: how opposites chemoattract. Cell 109:541–544. doi:10.1016/S0092-8674(02)00765-1
Deshpande DA, Pascual RM, Wang SW, Eckman DM, Riemer EC, Funk CD, Penn RB (2007) PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. FASEB J 21:2335–2342. doi:10.1096/fj.06-8060com
Kuehn HS, Gilfillan AM (2007) G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunol Lett 113:59–69. doi:10.1016/j.imlet.2007.08.007
Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005) Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65:1433–1441. doi:10.1158/0008-5472.CAN-04-1163
Paolucci L, Rozengurt E (1999) Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Res 59:572–577
Zugaza JL, Sinnett-Smith J, Van Lint J, Rozengurt E (1996) Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J 15:6220–6230
Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607–614. doi:10.1126/science.1411571
Moscat J, Rennert P, Diaz-Meco MT (2006) PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ 13:702–711. doi:10.1038/sj.cdd.4401823
Rabinovitz I, Toker A, Mercurio AM (1999) Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J Cell Biol 146:1147–1160. doi:10.1083/jcb.146.5.1147
Parsons M, Keppler MD, Kline A, Messent A, Humphries MJ, Gilchrist R, Hart IR, Quittau-Prevostel C, Hughes WE, Parker PJ, Ng T (2002) Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol 22:5897–5911. doi:10.1128/MCB.22.16.5897-5911.2002
Kruger JS, Reddy KB (2003) Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 1:801–809
Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A (2004) Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem 279:14551–14560. doi:10.1074/jbc.M311981200
Etienne-Manneville S, Hall A (2001) Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106:489–498. doi:10.1016/S0092-8674(01)00471-8
Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421:753–756. doi:10.1038/nature01423
Hirai T, Chida K (2003) Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem 133:1–7. doi:10.1093/jb/mvg017
Joberty G, Petersen C, Gao L, Macara IG (2000) The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2:531–539. doi:10.1038/35019573
Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T (2000) A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol 2:540–547. doi:10.1038/35019592
Giagulli C, Scarpini E, Ottoboni L, Narumiya S, Butcher EC, Constantin G, Laudanna C (2004) RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity 20:25–35. doi:10.1016/S1074-7613(03)00350-9
Laudanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC (1998) Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 273:30306–30315. doi:10.1074/jbc.273.46.30306
Liu Y, Wang B, Wang J, Wan W, Sun R, Zhao Y, Zhang N (2009) Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 63:210–218. doi:10.1016/j.lungcan.2008.05.010
Guo H, Ma Y, Zhang B, Sun B, Niu R, Ying G, Zhang N (2009) Pivotal Advance: PKC{zeta} is required for migration of macrophages. J Leukoc Biol
Rodems SM, Hamman BD, Lin C, Zhao J, Shah S, Heidary D, Makings L, Stack JH, Pollok BA (2002) A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. Assay Drug Dev Technol 1:9–19. doi:10.1089/154065802761001266
Doerr ME, Jones JI (1996) The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 271:2443–2447. doi:10.1074/jbc.271.5.2443
Zigmond SH, Joyce M, Borleis J, Bokoch GM, Devreotes PN (1997) Regulation of actin polymerization in cell-free systems by GTPgammaS and Cdc42. J Cell Biol 138:363–374. doi:10.1083/jcb.138.2.363
Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS (2004) Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304:743–746. doi:10.1126/science.1094561
Sharkey NA, Leach KL, Blumberg PM (1984) Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci USA 81:607–610. doi:10.1073/pnas.81.2.607
Podar K, Raab MS, Chauhan D, Anderson KC (2007) The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opin Investig Drugs 16:1693–1707. doi:10.1517/13543784.16.10.1693
Acknowledgement
The authors thank Tianjin Commission of Science and Technology (06TXTJJC14502), National 973 program (2006CB705600), National 863 program (2006AA02Z190), NSFC (30772528) and NSFC (30772529) for financial supports.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wu, J., Zhang, B., Wu, M. et al. Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis. Invest New Drugs 28, 268–275 (2010). https://doi.org/10.1007/s10637-009-9242-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-009-9242-8